A ProMED-mail post
Archive Number: 20121127.1426895
 Vaccination campaign status
Date: Sun 25 Nov 2012
Source: Examiner [edited]
Progress in getting the 2.2 million people in Darfur vaccinated against the yellow fever virus moves forward as thousands gather in vaccination points in targeted localities in the region. In just one day, 13 per cent of the target population in Geneina, Kerinik, Habila, and Beidha in West Darfur were vaccinated, according to a World Health Organization Situation Report of 22 Nov 2012.
During the 12-day emergency response vaccination campaign, some 2.2 million population in 12 prioritized localities are targeted for the vaccination.
Yesterday [24 Nov 2012], the campaign began in the Northern Darfur localities of Saraf Omra and Seref. While the necessary vaccine campaign goes through the various localities, the number of yellow fever cases and fatalities continue to rise.
[The yellow fever vaccination campaign appears to be moving ahead swiftly, as it moves toward its stated goal of having individuals in all critical area vaccinated within 10-12 days — now nearly half over. The European Commission indicated that it is ready to help the Sudanese government cope with this recent outbreak of yellow fever. The Commission, as part of the campaign, has already deployed humanitarian experts on the ground to monitor the disease outbreak along with several NGOs [nongovernmental organizations] and humanitarian groups.
Kristalina Georgieva, European Commissioner for International Cooperation, Humanitarian Aid and Crisis Response stated, “To ensure that all people at risk are vaccinated, it is essential that all affected areas are covered by the campaign, including those which have been inaccessible to humanitarian agencies in the past.” (see http://allafrica.com/stories/201211270337.html. So far, there has been no mention of what the plans and activities are after the 10-12 day vaccination campaign has ended. It is unlikely that all people in Darfur will have been vaccinated, leaving the possibility of small-scale, smoldering foci of transmission and sporadic cases in more remote, lesser populated areas. Thorough surveillance will be necessary with vaccination teams ready to move into those areas to halt resumption of the outbreaks.